InvestorsHub Logo
Followers 8
Posts 357
Boards Moderated 0
Alias Born 07/30/2015

Re: lesgetrich post# 2230

Monday, 03/20/2017 5:04:58 PM

Monday, March 20, 2017 5:04:58 PM

Post# of 9941
Teewinot is doing biosynthesis for several companies which is cost effective and fast. Other than GW, nobody is going to develop a drug using the plant. It won't get approved for one and it's too costly and inefficient for another. It seems that InMed is doing it differently but I have no idea if it's better or cheaper or faster. Perhaps others can shed light on it.

InMed intrigues me because there could be something there. I just can't tell if what they have has value. They're probably 2 years away from being able to make their drug and don't have any approved patents yet from what I can tell.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News